​

Oncology Institute (TOI) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TOI Stock Forecast

Oncology Institute (TOI) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $8.00, with a high of $8.00 and a low of $8.00. This represents a 61.29% increase from the last price of $4.96.

- $1 $2 $3 $4 $5 $6 $7 $8 High: $8 Avg: $8 Low: $8 Last Closed Price: $4.96

TOI Stock Rating

Oncology Institute stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

TOI Price Target Upside V Benchmarks

TypeNameUpside
StockOncology Institute61.29%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks27.59%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$8.00$8.00$6.50
Last Closing Price$4.96$4.96$4.96
Upside/Downside61.29%61.29%31.05%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 2613---4
May, 2613---4
Apr, 2613---4
Mar, 2613---4
Feb, 2613---4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 08, 2026David LarsenBTIG$8.00$4.8764.27%61.29%
Nov 25, 2025Matthew SheaNeedham$5.00$3.0464.47%0.81%
Nov 11, 2022Guggenheim$6.00$2.50140.00%20.97%
Aug 15, 2022Jefferies$10.00$6.4455.28%101.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 08, 2026BTIGBuyBuyhold
Nov 25, 2025NeedhamBuyinitialise
May 15, 2025BTIGBuyinitialise
Nov 11, 2022GuggenheimBuyBuyhold
Aug 15, 2022JefferiesBuyinitialise

Financial Forecast

EPS Forecast

Dec 22 Dec 23 Dec 24 Dec 25
Dec 22Dec 23Dec 24Dec 25
Reported-$-0.92$-0.71$-0.54
Avg Forecast$-0.28$-0.51$-0.36$-0.17
High Forecast$-0.28$-0.51$-0.36$-0.17
Low Forecast$-0.28$-0.51$-0.36$-0.17
Surprise %-80.39%97.22%217.65%

Revenue Forecast

$200M $270M $340M $410M $480M $550M Dec 22 Dec 23 Dec 24 Dec 25
Dec 22Dec 23Dec 24Dec 25
Reported$252.48M$324.24M$393.41M$502.73M
Avg Forecast$245.76M$320.50M$414.70M$482.80M
High Forecast$245.76M$320.50M$414.70M$482.80M
Low Forecast$245.76M$320.50M$414.70M$482.80M
Surprise %2.74%1.17%-5.13%4.13%

Net Income Forecast

$-85M $-67M $-49M $-31M $-13M $5M Dec 22 Dec 23 Dec 24 Dec 25
Dec 22Dec 23Dec 24Dec 25
Reported$152.00K$-83.07M$-64.66M$-60.61M
Avg Forecast$-20.65M$-37.61M$-26.55M$-12.54M
High Forecast$-20.65M$-37.61M$-26.55M$-12.54M
Low Forecast$-20.65M$-37.61M$-26.55M$-12.54M
Surprise %-100.74%120.86%143.56%383.41%

TOI Forecast FAQ

Is Oncology Institute stock a buy?

Oncology Institute stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Oncology Institute is a favorable investment for most analysts.

What is Oncology Institute's price target?

Oncology Institute's price target, set by 5 Wall Street analysts, averages $8 over the next 12 months. The price target range spans from $8 at the low end to $8 at the high end, suggesting a potential 61.29% change from the previous closing price of $4.96.

How does Oncology Institute stock forecast compare to its benchmarks?

Oncology Institute's stock forecast shows a 61.29% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (27.59%).

What is the breakdown of analyst ratings for Oncology Institute over the past three months?

  • June 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.